An independent weekly newsletter reporting on cannabis, psychedelics and plant medicine, with close readings of new studies and their limits. Each issue pairs a lead science item and quick hits with desk sections on science, markets and culture.

Long-form essays on psychedelic research, covering pharmacology, policy, philosophy of mind and the cultural and anthropological contexts of DMT and related compounds. Writing is by Stephen Page and draws on academic sources, including coursework from an Exeter MSc, to examine how psychedelic experience and its history are interpreted.

A newsletter offering critical, reported analysis of psychedelics and spirituality, including case studies of difficult post-psychedelic experiences and scrutiny of the industry and government policy. Readers get narrative reporting and evidence-based commentary on psychedelic safety and regulation.

Essays on psychedelic therapy, integration, and the psychology of personal change, covering topics such as dosing, risks, and how cultural frameworks shape psychedelic experiences. Readers get reflective, evidence-aware analysis that avoids both hype and alarmism.